“Advancements in Minimally Invasive Cardiac Interventions”
- A significant and accelerating trend in the Vietnam interventional cardiology market is the growing adoption of minimally invasive procedures for the diagnosis and treatment of cardiovascular diseases. These interventions, such as angioplasty and stent placements, are becoming increasingly preferred over traditional open-heart surgeries due to shorter recovery times, reduced hospital stays, and lower risk of complications
- For instance, Vietnam has seen a rise in the number of cardiac catheterization labs, enabling broader access to percutaneous coronary intervention (PCI) and coronary thrombectomy procedures. This expansion is supported by increased government investment in cardiovascular infrastructure and the integration of advanced imaging techniques
- The market is also witnessing significant growth due to the increasing prevalence of cardiovascular conditions, including ischemic heart disease and coronary artery disease, particularly in the aging population. The rising number of geriatric patients has increased the demand for less invasive solutions with better clinical outcomes
- Moreover, advancements in drug-eluting stents (DES), balloon angioplasty devices, and intravascular ultrasound (IVUS) systems are enhancing procedural success rates and long-term efficacy, further driving market penetration
- Companies operating in the market are focusing on launching next-generation guidewires, catheters, and fractional flow reserve (FFR) technologies to provide more accurate, safe, and effective interventions. Strategic collaborations between hospitals and medical device manufacturers are also improving procedural capabilities and clinical expertise across Vietnam
- The demand for interventional cardiology solutions is rapidly increasing across hospitals and cath labs, as the country continues to prioritize cardiovascular health through public health programs, skilled physician training, and access to modern cardiac care facilities
